北美数字治疗 (DTx) 市场，按产品和服务类型（硬件产品、解决方案/软件、服务）、应用（治疗/护理相关应用、预防应用）、购买模式（团购组织、个人）、销售渠道（B2B、B2C）、国家（美国、加拿大、墨西哥）行业趋势和预测到 2028 年
市场分析和洞察：北美数字治疗 (DTx) 市场
数字治疗 (DTx) 市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 23.4%，预计到 2028 年将达到 106.3936 亿美元。糖尿病、高血压等慢性病患病率的不断增加以及政府机构认识的不断提高将促进数字治疗 (DTx) 市场的增长。
数字疗法 (DTx) 使用基于证据的远程评估软件直接向患者提供治疗干预，以治疗、管理和预防各种行为、精神和身体疾病。它们可以单独使用，也可以与药物、设备或其他疗法结合使用，以优化患者护理和健康结果。在治疗过程中，越来越多地远程访问经过临床测试的、安全有效的疗法是数字疗法 (DTx) 的特性之一。
公司为扩大产品线和获取利润而进行的技术进步是数字治疗 (DTx) 市场增长的驱动力之一。与数字治疗 (DTx) 应用程序相关的隐私问题可能会成为数字治疗 (DTx) 市场增长的制约因素。公司之间的合作将有助于市场增长，并为数字治疗 (DTx) 市场带来机遇。为了为客户提供更好的治疗和适当的护理，必须保持数字治疗 (DTx) 的质量，因此，这需要正确完成，因此，这将对数字治疗 (DTx) 市场构成挑战，因为很多时候需求得不到满足。
数字治疗 (DTx) 市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和数字治疗 (DTx) 市场情景，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
数字治疗 (DTx) 市场范围和市场规模
数字治疗 (DTx) 市场根据产品和服务类型、应用、购买模式和销售渠道分为四个部分。各部分之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品和服务类型，数字治疗 (DTx) 市场细分为硬件产品、解决方案/软件和服务。2021 年，由于智能手机用户数量增加，解决方案/软件领域预计将占据市场主导地位。
- 根据应用，数字治疗 (DTx) 市场细分为治疗/护理相关应用和预防应用。2021 年，治疗/护理相关应用领域预计将占据主导地位，因为它提供了良好的治疗并改善了人们的生活方式。
- 根据购买模式，数字治疗 (DTx) 市场细分为团体购买组织和个人。2021 年，个人细分市场预计将占据市场主导地位，因为许多人在疫情期间接受数字医疗平台并更喜欢它们。
- 根据销售渠道，数字治疗 (DTx) 市场分为 B2B 和 B2C。2021 年，B2C 市场预计将占据市场主导地位，因为这些服务大多直接面向客户。
北美数字治疗 (DTx) 市场国家级分析
对北美数字治疗 (DTx) 市场进行分析，并按上述国家、产品和服务类型、应用、购买模式和销售渠道提供市场规模信息。
北美数字治疗 (DTx) 市场报告涵盖的国家包括美国、加拿大和墨西哥。
北美地区在数字治疗 (DTx) 市场中占有大部分份额，预计由于糖尿病病例数增加，该地区在预测期内将出现复合年增长率。美国是世界上家庭支出最高的国家，并与多个国家签订了贸易协定，使其成为包括数字治疗 (DTx) 产品在内的消费品的最大市场
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
制造商的战略举措为数字治疗 (DTx) 市场的参与者创造了新的机遇
数字治疗 (DTx) 市场还为您提供每个国家数字治疗 (DTx) 产品销售增长、数字治疗 (DTx) 进步的影响以及监管环境的变化及其对数字治疗 (DTx) 市场的支持的详细市场分析。数据涵盖 2011 年至 2019 年的历史时期。
竞争格局和数字治疗 (DTx) 市场份额分析
数字治疗 (DTx) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对数字治疗 (DTx) 市场的关注有关。
北美数字治疗 (DTx) 市场报告涵盖的主要参与者包括 Fitbit, Inc.、Livongo、ResMed、Omada Health, Inc.、Noom, Inc.、Happify, Inc.、Welldoc, Inc.、SAMSUNG、ATENTIV、MANGO HEALTH、CogniFit、Kaia Health、Mindstrong Health、Smartpatient gmbh、Ayogo Health Inc.、Ginger、Better Therapeutics, Inc.、2Morrow Inc.、CANARY HEALTH、Click Therapeutics, Inc.、Cognoa、Pear Therapeutics, Inc.、Voluntis、Akili Interactive Labs, Inc. 以及其他国内参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
全球各地的公司也推出了许多产品并达成了多项协议，这也加速了数字治疗 (DTx) 市场的发展。
例如，
- 2019年8月，ATENTIV与儿童专科医院中心达成协议。双方的合作包括共同开发统一的行为和基本治疗操作系统，该系统利用最佳临床实践，供初级保健临床医生使用ATENTIV mynd。此次合作将提高公司的品牌价值和产品的市场价值。
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在数字治疗 (DTx) 市场中的市场，这也为组织改善其数字治疗 (DTx) 产品提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 NORTH AMERICA DIGITAL THERAPEUTICS (DTX) MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES
5.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE
5.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES
5.1.5 IMPROVED QUALITY OF LIFE
5.2 RESTRAINTS
5.2.1 PATIENT INFORMATION PRIVACY POLICIES
5.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS
5.2.3 UNDER DEVELOPING COUNTIRES LACKING SMARTPHONES AND INTERNET FACILITIES
5.3 OPPORTUNITIES
5.3.1 RISING DEMAND OF DIGITAL THERAPEUTICS
5.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES
5.3.3 PARTNERSHIP BETWEEN COMPANIES
5.3.4 EXPANSION AND LAUNCH OF PRODUCTS
5.3.5 EVENTS AND EXHIBITION
5.3.6 PHYSICIAN ADOPTION
5.4 CHALLENGES
5.4.1 CLINICAL VALIDATION
5.4.2 REGULATORY APPROVAL
5.4.3 PAYER REIMBURSEMENT
6 IMPACT OF COVID-19 ON NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
6.1 IMPACT ON DEMAND
6.2 IMPACT ON SUPPLY
6.3 KEY INITIATIVES TAKEN BY PLAYERS DURING COVID-19
6.4 CONCLUSION
7 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE
7.1 OVERVIEW
7.2 SOLUTION/SOFTWARE
7.3 HARDWARE PRODUCTS
7.4 SERVICE
8 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 TREATMENT/CARE-RELATED APPLIACTIONS
8.2.1 DIABETES
8.2.2 CENTRAL NERVOUS SYSTEM DISORDERS
8.2.3 SMOKING CESSATION
8.2.4 CHRONIC RESPIRATORY DISEASES
8.2.5 MUSCULOSKELETAL DISORDER
8.2.6 CARDIOVASCULAR DISEASES
8.2.7 MEDICATION ADHERENCE
8.2.8 GASTROINTESTINAL DISORDERS
8.2.9 REHABILITATION AND PATIENT CARE
8.2.10 SUBSTANCE USE DISORDER AND ADDICTION MANAGEMENT
8.2.11 OTHER TREATMENT/ CARE RELATED APPLICATIONS
8.3 PREVENTIVE APPLICATIONS
8.3.1 PREDIABETES
8.3.2 OBESITY
8.3.3 NUTRITION
8.3.4 LIFESTYLE MANAGEMENT
8.3.5 OTHER PREVENTIVE APPLICATIONS
9 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATION
9.2.1 SOLUTIONS/ SOFTWARE
9.2.2 HARDWARE PRODUCT
9.2.3 SERVICE
9.3 INDIVIDUAL
9.3.1 SOLUTIONS/ SOFTWARE
9.3.2 HARDWARE PRODUCT
9.3.3 SERVICE
10 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL
10.1 OVERVIEW
10.2 B2B
10.2.1 PAYERS
10.2.2 EMPLOYERS
10.2.3 PHARMA COMPANIES
10.2.4 PROVIDERS
10.2.5 OTHER BUYERS
10.3 B2C
10.3.1 CAREGIVERS
10.3.2 PATIENTS
11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 SWOT
14 COMPANY PROFILE
14.1 FITBIT,INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 LIVONGO
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 RESMED
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 OMADA HEALTH, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 GINGER
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 SAMSUNG
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 MINDSTRONG HEALTH
14.7.1 COMPANY SNAPSHOT
14.7.2 SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 2MORROW INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 AKILI INTERACTIVE LABS, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ATENTIV
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 AYOGO HEALTH INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 BETTER THERAPEUTICS, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 CANARY HEALTH
14.13.1 COMPANY SNAPSHOT
14.13.2 SOLUTION PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CLICK THERAPEUTICS, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 COGNIFIT
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 COGNOA
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 GAIA AG
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 HAPPIFY, INC.
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
14.19 KAIA HEALTH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MANGO HEALTH
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
14.21 NATURAL CYCLES USA CORP
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 NOOM, INC.
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENT
14.23 PEAR THERAPEUTICS, INC.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 SMARTPATIENT GMBH
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 VOLUNTIS
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENTS
14.26 WELLDOC, INC.
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 WELLTHY THERAPEUTICS PVT LTD
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
表格列表
LIST OF TABLES
TABLE 1 REGULATORY FRAMEWORK
TABLE 2 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
TABLE 3 NORTH AMERICA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))
TABLE 4 NORTH AMERICA HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
TABLE 7 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)
TABLE 12 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)
TABLE 17 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 32 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 33 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 34 U.S. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 35 U.S. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 36 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 37 U.S. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 38 U.S. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 39 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 40 U.S. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 U.S. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 42 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 43 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 CANADA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 45 CANADA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 46 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 47 CANADA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 48 CANADA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 49 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 CANADA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 CANADA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 53 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 MEXICO TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 MEXICO PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 57 MEXICO GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 58 MEXICO INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 59 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 MEXICO B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 MEXICO B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
图片列表
LIST OF FIGURES
FIGURE 1 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 12 INCREASING DEMAND OF DIGITAL THERAPEUTICS WORLDWIDE DUE TO PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2021 TO 2028.
FIGURE 13 SOLUTIONS/SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET
FIGURE 15 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020
FIGURE 16 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
FIGURE 17 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2021-2028)
FIGURE 18 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020
FIGURE 20 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 21 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020
FIGURE 24 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020-2028 (USD MILLION)
FIGURE 25 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2021-2028)
FIGURE 26 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020
FIGURE 28 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020-2028 (USD MILLION)
FIGURE 29 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2021-2028)
FIGURE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 31 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2020)
FIGURE 32 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020)
FIGURE 33 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2021 & 2028)
FIGURE 34 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020 & 2028)
FIGURE 35 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE (2021-2028)
FIGURE 36 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
